Tirzepatide is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist approved by the FDA for the treatment of type 2 diabetes mellitus and chronic weight management
It gives Novo Nordisk an opportunity to remain competitive on efficacy while it continues developing next-generation therapies. Other drugs have already shown greater efficacy in prior studies, and the broader GLP-1 space is likely to see much more significant change as new molecules enter the market. Balazs called the higher dosage a major jump, noting that the incidences of stomach- and skin-related side effects at this higher dose are meaningful. This approval is for obesity management, not diabetes treatment, the expert emphasized
10mg vial vs
Strength in numbers Gain insights and inspiration from peers in our community space
She defended the use of injections for weight loss, saying, "Someone like me could have a bottomless appetite for sweets, so I think those drugs can be good." The star also spoke to People, opening up about her unhealthy relationship with food and exercise
Some FDA safety tips on using an online pharmacy or telehealth service that fulfills prescriptions through an online pharmacy: Make sure getting the drug requires a doctors prescription, that the service has a US address and phone number, and is licensed with a state board or pharmacy